Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
2013 Apr 11
CC1N=CSC=1C1=CC=C(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCCN)C(C)(C)C)C=C1
PubMed Central PMCID: PMC4866285
Mirdametinib
Except some weak inhibitory activity against PKCα
B-HT 920 - CAS# 36085-73-1 Size:Solid 10 mg 2013 Apr 11Talipexole, also known as B HT920 and Domnin, is a dopamine agonist that is marketed as a treatment for Parkinson's Disease in Japan by Boehringer Ingelheim; it was introduced in 1996. As of December 2014 it was not approved for marketing in the US nor in Europe. Talipexole is a D2 dopamine receptor agonist and interacts both pre and post synaptic receptors. It also is an 2 adrenergic agonist. The main side effects are drowsiness, dizziness,
US$ 1099.50
US$ 180.00
US$ 180.00
US$ 1099.50
US$ 180.00
US$ 359.00
US$ 180.00
US$ 809.50